Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur Swift

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Journal of Cosmetic Dermatology|August 26, 2023
Decades of beauty: Achieving aesthetic goals throughout the lifespanJoel L Cohen, Greg J Goodman, Ada Trindade De Almeida, et al.
Aesthetic Surgery Journal|August 3, 2022
PrabotulinumtoxinA vs OnabotulinumtoxinA for the Treatment of Adult Males With Moderate to Severe Glabellar Lines: Post-hoc Analyses of the Phase III Clinical Study DataNowell Solish, Benjamin Ascher, Rui L Avelar, et al.
Aesthetic Surgery Journal|April 6, 2019
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Phase III, Non-Inferiority Study Comparing PrabotulinumtoxinA and OnabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult PatientsBerthold-Josef Rzany, Benjamin Ascher, Rui L Avelar, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Journal of Cosmetic Dermatology|August 26, 2023
Decades of beauty: Achieving aesthetic goals throughout the lifespanJoel L Cohen, Greg J Goodman, Ada Trindade De Almeida, et al.
Aesthetic Surgery Journal|August 3, 2022
PrabotulinumtoxinA vs OnabotulinumtoxinA for the Treatment of Adult Males With Moderate to Severe Glabellar Lines: Post-hoc Analyses of the Phase III Clinical Study DataNowell Solish, Benjamin Ascher, Rui L Avelar, et al.
Aesthetic Surgery Journal|April 6, 2019
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Phase III, Non-Inferiority Study Comparing PrabotulinumtoxinA and OnabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult PatientsBerthold-Josef Rzany, Benjamin Ascher, Rui L Avelar, et al.
Pageof 6